KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Intuitive Surgical (ISRG) Shares Outstanding (Diluted Average) (2016 - 2026)

Intuitive Surgical has reported Shares Outstanding (Diluted Average) over the past 18 years, most recently at $359.8 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 1.32% to $359.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $359.8 million through Mar 2026, down 1.32% year-over-year, with the annual reading at $362.7 million for FY2025, 0.19% changed from the prior year.
  • Shares Outstanding (Diluted Average) was $359.8 million for Q1 2026 at Intuitive Surgical, down from $362.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $366.7 million in Q1 2022 and troughed at $356.0 million in Q1 2023.
  • The 5-year median for Shares Outstanding (Diluted Average) is $362.0 million (2022), against an average of $361.4 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): fell 2.92% in 2023 and later rose 1.57% in 2024.
  • Tracing ISRG's Shares Outstanding (Diluted Average) over 5 years: stood at $362.0 million in 2022, then fell by 1.27% to $357.4 million in 2023, then grew by 1.29% to $362.0 million in 2024, then grew by 0.19% to $362.7 million in 2025, then fell by 0.8% to $359.8 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $359.8 million, $362.7 million, and $363.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.